Monocytic MDSCs regulate macrophage-mediated xenogenic cytotoxicity-Reference-Cited by-同舟云学术

Monocytic MDSCs regulate macrophage-mediated xenogenic cytotoxicity

Published:2015-10 Issue:2 Volume:33 Page:140-145
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Maeda Akira,Eguchi Hiroshi,Nakahata Kengo,Lo Pei-Chi,Yamanaka Kazuaki,Kawamura Takuji,Matsuura Rei,Sakai Rieko,Asada Mayumi,Okuyama Hiroomi,Miyagawa Shuji

Funder

Grants-in Aid for Scientific Research

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference31 articles.

1. Immune responses to alpha1,3-galactosyltransferase knockout pigs;Puga Yung;Curr. Opin. Organ Transplant.,2009

2. The role of macrophages in xenograft rejection;Cadili;Transplant. Proc.,2008

3. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population;Dorling;Eur. J. Immunol.,1996

4. Allogeneic and xenogeneic islets are rejected by different and specific mechanisms: a study in rodents using a mixed allogeneic–xenogeneic islet transplantation model;Wennberg;Xenotransplantation,1997

5. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses;Lin;J. Immunol.,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy;Journal of Hematology & Oncology;2023-06-05

2. Suppression of xenogeneic innate immune response by a membrane‑type human surfactant protein‑A;Experimental and Therapeutic Medicine;2022-07-26

3. Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers;Cells;2021-04-30

4. Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer;Cells;2021-02-05

5. Increased Serum Level of Interleukin-10 Predicts Poor Survival and Early Recurrence in Patients With Peripheral T-Cell Lymphomas;Frontiers in Oncology;2020-10-13